Germ Cell Tumors

A key management issue was the postoperative intensity of bleomycin, etoposide, and cisplatin (BEP) chemotherapy. The patient remains disease-free on follow-up. This case highlights the following two practical lessons: unusual ovarian germ cell tumors may remain unclassifiable despite integrated pathology, and adjuvant treatment decisions in stage I disease may depend not only on stage but also on staging adequacy and biologic uncertainty.

These findings demonstrate a distinct surface antigen landscape in testicular GCTs, with CLDN6, EGFR, and TROP2 emerging as leading candidates for further translational evaluation. Enrichment of these targets highlights antigenic heterogeneity within GCTs and supports further validation in appropriate disease settings including metastatic, post-treatment, and relapsed or refractory disease.

SM exhibits temporal, histologic, and molecular distinctions across primary sites. Response to front-line therapy and survival outcomes are poor. Future direction includes the exploration of underlying predictors of transformation and identification of targetable alterations in the relapsed setting.

Testicular germ cell tumors (TGCTs) are the most common solid malignancies in young men and, despite high cure rates with cisplatin-based multimodal therapy, a clinically relevant subset of patients develops relapsed, platinum-refractory, or treatment-resistant disease with limited salvage options and substantial long-term morbidity...We argue that the next phase of the field should move beyond descriptive biomarker studies toward mechanism-based, TGCT-specific translational strategies integrating miRNA mimics, antagomirs, extracellular vesicles, or miRNA-augmented cellular therapies with immune-priming approaches such as epigenetic therapy, radiotherapy, vaccines, or CAR-T platforms. Such a framework could enable more precise biological stratification and improve the efficacy, durability, and tolerability of immunotherapy in refractory TGCT.

Additional variants in MSH6 and CTU2 were also identified and may act as potential modifiers of disease susceptibility, consistent with a multigenic contribution to TGCT risk. These findings support a contributory role for the PDE11A locus in TGCT predisposition and underscore the biological relevance of overlapping sense-antisense genomic regions in hereditary cancer studies.

In 786-O and ACHN cells, chronic exposure to an environmentally relevant concentration of BaP significantly increased CASP9 protein stability without altering its mRNA expression, suggesting post-transcriptional regulation. Collectively, these findings identify shared molecular targets of EDCs across urogenital cancers and provide new mechanistic insight into EDC-driven tumor progression, prioritizing potential biomarkers and therapeutic targets for environmentally related malignancies.

These immunophenotypes are not specific because other epithelial and non-epithelial uterine tumors may exhibit overlapping features. Therefore, a comprehensive pathological understanding of UEC is essential for avoiding diagnostic pitfalls and improving diagnostic accuracy.

P=N/A, N=30, Recruiting, M.D. Anderson Cancer Center

P1, N=10, Not yet recruiting, Ottawa Hospital Research Institute

Immunohistochemical analysis revealed a Cytokeratin (CK) 7-negative/CK19-positive immunophenotype and moderate hCG expression (++). In postpartum patients with unexplained β-hCG elevation unrelated to pregnancy, ectopic β-hCG-secreting tumors, such as ICC, should be considered in the differential diagnosis after exclusion of trophoblastic and germ cell neoplasms, particularly when accompanied by elevated carbohydrate antigen 19-9 levels.

These findings raise suspicion for Lynch syndrome. This case is interesting because seminoma and colorectal cancer were both identified in a patient with features suggestive of a hereditary cancer syndrome.

miR-371a-3p and cfDNA provide independent information in TGCT, miR-371a-3p being associated with the active disease presence, while total cfDNA levels are increased during the active treatment, reflecting different biology and dynamics of the two circulating biomarkers. These findings have implications for future studies on disease monitoring in TGCT. The sensitivity of miR-371a-3p detection in this real practice cohort is lower than reported previously, suggesting assay standardization and clinical studies setting are warranted before miR-371a-3p implementation into clinical practice.